Alliance for Multispecialty Research & UT Medical Center Participate in Global RSV Vaccine Trial Investigating Pfizer’s RSV Vaccine Candidate

Alliance for Multispecialty Research & UT Medical Center Participate in Global RSV Vaccine Trial Investigating Pfizer’s RSV Vaccine Candidate

Physicians serving as clinical investigators in Knoxville, Tennessee, working for Alliance for Multispecialty Research (AMR) and the University of Tennessee Medical Center, initiated a clinical trial targeting a vaccine for respiratory syncytial virus (RSV), a common, contagious virus triggering infections in the respiratory tract. A negative-sense, single-stranded RNA virus, RSV, represents the single most common cause of respiratory hospitalization in infants, while reinfection remains a problem later in life. This study is led by AMR’s founder, president, and principal investigator Dr. William Smith.

The Condition

The Centers for Disease Control and Prevention (CDC) estimates that over 177,000 older adults are hospitalized annually with 14,000 deaths due to RSV. By 2018, AMR reports that more Americans died from RSV infection than the common flu.

The virus is most commonly found in children from newborn to four (4) years old. But this virus can manifest later in life, much like the flu or coronavirus, triggering long-term damage to the lungs, for example. The condition can lead to life-threatening situations.

In 2018, Pfizer reported that about 33 million cases of R...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee